Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$36.71 - $44.15 $2.29 Million - $2.75 Million
-62,281 Reduced 85.62%
10,460 $435,000
Q1 2023

May 15, 2023

SELL
$36.81 - $48.12 $9.61 Million - $12.6 Million
-261,130 Reduced 78.21%
72,741 $3 Million
Q4 2022

Feb 14, 2023

SELL
$35.68 - $44.71 $57.5 Million - $72.1 Million
-1,612,402 Reduced 82.85%
333,871 $13.8 Million
Q3 2022

Nov 14, 2022

BUY
$42.51 - $54.02 $20.6 Million - $26.2 Million
485,561 Added 33.24%
1,946,273 $85.3 Million
Q2 2022

Aug 15, 2022

SELL
$46.84 - $59.75 $382,870 - $488,396
-8,174 Reduced 0.56%
1,460,712 $71.8 Million
Q1 2022

May 16, 2022

BUY
$48.09 - $57.79 $6.4 Million - $7.69 Million
133,068 Added 9.96%
1,468,886 $83.3 Million
Q4 2021

Feb 14, 2022

BUY
$47.19 - $62.68 $49 Million - $65.1 Million
1,038,724 Added 349.63%
1,335,818 $70.1 Million
Q3 2021

Nov 15, 2021

SELL
$56.91 - $67.81 $16.1 Million - $19.2 Million
-282,884 Reduced 48.77%
297,094 $17.8 Million
Q2 2021

Aug 16, 2021

BUY
$64.02 - $71.72 $17.7 Million - $19.8 Million
275,818 Added 90.68%
579,978 $39.3 Million
Q1 2021

May 17, 2021

SELL
$53.26 - $68.08 $50.5 Million - $64.5 Million
-947,981 Reduced 75.71%
304,160 $19.9 Million
Q4 2020

Feb 16, 2021

SELL
$43.41 - $56.51 $33.9 Million - $44.1 Million
-780,184 Reduced 38.39%
1,252,141 $70.5 Million
Q3 2020

Nov 16, 2020

BUY
$47.43 - $60.75 $14.7 Million - $18.8 Million
309,578 Added 17.97%
2,032,325 $98.7 Million
Q2 2020

Aug 14, 2020

BUY
$43.51 - $66.59 $20.3 Million - $31.1 Million
467,396 Added 37.23%
1,722,747 $95.9 Million
Q1 2020

May 15, 2020

BUY
$32.82 - $81.13 $8.71 Million - $21.5 Million
265,434 Added 26.81%
1,255,351 $63.6 Million
Q4 2019

Feb 14, 2020

BUY
$60.96 - $77.7 $28.3 Million - $36.1 Million
464,219 Added 88.31%
989,917 $76.6 Million
Q3 2019

Nov 14, 2019

BUY
$55.78 - $68.08 $23.7 Million - $28.9 Million
424,514 Added 419.55%
525,698 $33.3 Million
Q2 2019

Aug 14, 2019

SELL
$53.69 - $65.47 $5.6 Million - $6.83 Million
-104,334 Reduced 50.77%
101,184 $5.92 Million
Q1 2019

May 15, 2019

BUY
$44.53 - $58.9 $3.42 Million - $4.52 Million
76,758 Added 59.61%
205,518 $0
Q4 2018

Feb 14, 2019

BUY
$47.64 - $71.26 $5.83 Million - $8.71 Million
122,294 Added 1891.34%
128,760 $6.38 Million
Q3 2018

Nov 13, 2018

BUY
$52.03 - $71.41 $62,123 - $85,263
1,194 Added 22.65%
6,466 $0
Q2 2018

Aug 10, 2018

SELL
$48.15 - $56.68 $1.96 Million - $2.3 Million
-40,635 Reduced 88.52%
5,272 $0
Q1 2018

May 11, 2018

SELL
$46.03 - $61.28 $76.7 Million - $102 Million
-1,666,658 Reduced 97.32%
45,907 $2.4 Million
Q4 2017

Feb 09, 2018

BUY
$50.58 - $60.79 $37.5 Million - $45.1 Million
741,423 Added 76.35%
1,712,565 $100 Million
Q3 2017

Nov 09, 2017

BUY
$53.54 - $68.0 $52 Million - $66 Million
971,142
971,142 $53.9 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.